Bioaffinity Technologies Inc (BIAF)

Jun 18, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading 2.1% Higher – What’s Next? - Defense World

Jun 18, 2025

Jun 13, 2025

bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga

Jun 13, 2025

Jun 13, 2025

BIAF’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 13, 2025

Jun 13, 2025

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 13, 2025

Jun 12, 2025

Kalkine : bioAffinity Technologies BIAF Nasdaq Composite - Kalkine Media

Jun 12, 2025

Jun 12, 2025

bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Large Growth in Short Interest - Defense World

Jun 12, 2025

Jun 12, 2025

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board - BioSpace

Jun 12, 2025

Jun 11, 2025

bioAffinity CEO Joins American Lung Association Texas Leadership Board | BIAFW Stock News - Stock Titan

Jun 11, 2025

Jun 10, 2025

Gordon Downie Named Chief Medical Officer at bioAffinity Technologies - Medical Product Outsourcing

Jun 10, 2025

Jun 05, 2025

BIAFbioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - Revista ADVFN

Jun 05, 2025

Jun 04, 2025

Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - mx.advfn.com

Jun 04, 2025

Jun 03, 2025

bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung - Yahoo Finance

Jun 03, 2025

Jun 03, 2025

Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAF) Grows By 58.8% - Defense World

Jun 03, 2025

May 30, 2025

bioAffinity Receives Nasdaq Non-Compliance Notice - TipRanks

May 30, 2025

May 29, 2025

BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors - Insider Monkey

May 29, 2025

May 28, 2025

BioAffinity Technologies Announces New U.S. Patent For Novel Broad Spectrum Cancer Therapeutics - marketscreener.com

May 28, 2025

May 28, 2025

BIAF Gains New Patent for Innovative Cancer Treatment Method | B - GuruFocus

May 28, 2025

May 28, 2025

Revolutionary Cancer Treatment Patent: bioAffinity's New Therapy Kills Cancer Cells While Sparing Healthy Ones - Stock Titan

May 28, 2025

May 27, 2025

bioAffinity Technologies Enters Sales Agreement with WallachBeth - TipRanks

May 27, 2025

May 22, 2025

bioAffinity Technologies (NASDAQ:BIAF) Trading Down 3.1% – What’s Next? - Defense World

May 22, 2025

May 22, 2025

BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline - MSN

May 22, 2025

May 20, 2025

bioAffinity Technologies names new chief medical officer By Investing.com - Investing.com South Africa

May 20, 2025

May 20, 2025

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer - citybiz

May 20, 2025

May 20, 2025

BioAffinity Technologies (BIAF) Appoints Gordon Downie as Chief Medical Officer | BIAF Stock News - GuruFocus

May 20, 2025

May 20, 2025

bioAffinity Technologies names new chief medical officer - Investing.com Australia

May 20, 2025

May 20, 2025

From Olympic Bronze to Cancer Breakthrough: bioAffinity Names Elite Physician as New CMO - Stock Titan

May 20, 2025

May 20, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

May 20, 2025

May 19, 2025

bioAffinity Technologies Sets 2025 Annual Meeting Date - TipRanks

May 19, 2025

May 19, 2025

Earnings roundup: ‘Uncertain’ conditions weigh on companies’ bottom lines - San Antonio Express-News

May 19, 2025

May 18, 2025

bioAffinity Technologies Reports Strong Q1 2025 Growth - MSN

May 18, 2025

May 15, 2025

bioAffinity Technologies, Inc. SEC 10-Q Report - TradingView

May 15, 2025

May 15, 2025

bioAffinity Technologies Reports First Quarter 2025 Results - Business Wire

May 15, 2025

May 08, 2025

bioAffinity Technologies Completes $3.2M Public Offering - TipRanks

May 08, 2025

May 08, 2025

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering - The Malaysian Reserve

May 08, 2025

May 08, 2025

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer - Stock Titan

May 08, 2025

May 08, 2025

bioAffinity announces $3.25 million securities offering By Investing.com - Investing.com Nigeria

May 08, 2025

May 07, 2025

bioAffinity Technologies completes $3.25 million offering By Investing.com - Investing.com South Africa

May 07, 2025

May 07, 2025

BioAffinity Technologies Closes $3.25 Million Offering - marketscreener.com

May 07, 2025

May 07, 2025

bioAffinity Technologies (BIAF) Completes $3.25M Securities Offering | BIAF Stock News - GuruFocus

May 07, 2025

May 07, 2025

bioAffinity Technologies completes $3.25 million offering - Investing.com

May 07, 2025

May 07, 2025

bioAffinity Technologies Announces Closing of $3.25 Million Offering - Bluefield Daily Telegraph

May 07, 2025

May 07, 2025

bioAffinity Technologies Boosts Data Acquisition for CyPath Lung Test - Medical Product Outsourcing

May 07, 2025

May 07, 2025

BioAffinity Technologies announces pricing of $3.25M offering - Yahoo Finance

May 07, 2025

May 06, 2025

Crude Oil Rises Sharply; US Trade Deficit Widens In March - Benzinga

May 06, 2025

May 06, 2025

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering - Eastern Progress

May 06, 2025

May 06, 2025

The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies - NewsBreak: Local News & Alerts

May 06, 2025

May 06, 2025

Cancer Detection Biotech bioAffinity Secures Fresh $3.25M Funding: Key Details of Latest Stock Offering - Stock Titan

May 06, 2025

May 06, 2025

bioAffinity announces $3.25 million securities offering - Investing.com Australia

May 06, 2025

May 06, 2025

Dow Falls Over 250 Points; Marriott Posts Upbeat Earnings - Benzinga

May 06, 2025